I am very pleased to announce that the New York Genome Center (www.nygenome.org) is one of two new AIRI members.
NYGC is a consortium of renowned academic, medical and industry leaders across the globe, focused on translating genomic research into clinical solutions for serious disease. The twelve institutional founding members include three AIRI institutes: Cold Spring Harbor Laboratory; The Jackson Laboratory; and The Rockefeller University.
The New York Genome Center’s headquarters is located at 101 Avenue of the Americas, where the SoHo, Tribeca, and Hudson Square neighborhoods meet. Their facility serves as a state-of-the-art hub for genome sequencing, analytics, bioinformatics, high-performance computing, and research. Through their Integrated Genomic Solution, NYGC connects, services, and collaborates with academic, research, and medical institutions, as well as pharmaceutical, biotech, and IT companies.
The facility’s features include:
- 30,000 square feet of sequencing lab space with capacity for more than 80 Illumina HiSeq machines or the equivalent; this is more sequencing capacity than any other single institution in the city
- A dedicated open-plan bioinformatics floor to encourage discussion and collaboration
- A data storage annex to safely store the immense amounts of data produced
- Translational research labs with space to host a number of principal investigators and their teams from various member institutions
- An Innovation Lab to test and evaluate new sequencing technologies
- A CLIA lab to service clinical needs
- A modern, divisible conference center/event space with the capacity to hold 180 people for both NYGC and external events
NYGC has an additional connection to AIRI. This month Cheryl Moore assumed the roles of president and COO. She will be responsible for all business functions of NYGC, reporting to and partnering with Founding Director and CEO Robert Darnell, MD, PhD, to set overall strategic direction and make key business decisions for the organization. Cheryl comes to NYGC after five years as the executive vice president and COO of the Howard Hughes Medical Institute, where she led collaborative strategic efforts and oversaw key operational functions. From 2004 to 2010, she served as COO of HHMI's Janelia Research Campus, where she was responsible for all operational aspects of the campus and its $100 million budget. Prior to HHMI, Moore served as senior vice president and COO of the Sanford Burnham Prebys Medical Discovery Institute. Cheryl has been an active AIRI member for over 15 years serving on many AIRI committees, leading the AIRI President’s Forum, serving as Program and Break-out Chair, and serving on its Board of Directors.